These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35340837)

  • 21. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Lei T; Li J; Zhong H; Zhang H; Jin Y; Wu J; Li L; Xu B; Song Q; Hu Q
    Front Oncol; 2021; 11():680615. PubMed ID: 34336667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of postoperative radiotherapy on the survival of patients with resectable stage III-N2 non-small-cell lung cancer: a systematic review and meta-analysis.
    Zhang H; Zhang DX; Ju T; Zhou J
    Neoplasma; 2019 Sep; 66(5):717-726. PubMed ID: 31129967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
    Moretti L; Yu DS; Chen H; Carbone DP; Johnson DH; Keedy VL; Putnam JB; Sandler AB; Shyr Y; Lu B
    Oncologist; 2009 Nov; 14(11):1106-15. PubMed ID: 19897534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.
    Tsuboi M; Ohira T; Saji H; Miyajima K; Kajiwara N; Uchida O; Usuda J; Kato H
    Ann Thorac Cardiovasc Surg; 2007 Apr; 13(2):73-7. PubMed ID: 17505412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy for patients with completely resected pathologic IIIA(N2) non-small-cell lung cancer: a retrospective analysis.
    Zhu Y; Fu L; Jing W; Kong L; Yu J
    Cancer Manag Res; 2019; 11():10901-10908. PubMed ID: 32021415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients.
    Gao F; Li N; Xu Y; Yang G
    Front Oncol; 2020; 10():1135. PubMed ID: 32850322
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
    Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
    Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
    Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
    BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
    J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
    Shen WY; Ji J; Zuo YS; Pu J; Xu YM; Zong CD; Tao GZ; Chen XF; Ji FZ; Zhou XL; Han JH; Wang CS; Yi JG; Su XL; Zhu WG
    Radiother Oncol; 2014 Jan; 110(1):120-5. PubMed ID: 24183868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative radiotherapy for patients with completely resected stage IIIA-N2 non-small cell lung cancer: opt-in or opt-out.
    Zhu L; Xia B; Ma S
    Thorac Cancer; 2022 Mar; 13(5):659-663. PubMed ID: 35106937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of postoperative radiotherapy for patients with non-small cell lung cancer: An updated systematic review and meta-analysis.
    Wang Z; Yang B; Zhan P; Wang L; Wan B
    J Cancer Res Ther; 2022 Dec; 18(7):1910-1918. PubMed ID: 36647949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative radiotherapy for non-small cell lung cancer.
    Burdett S; Rydzewska L; Tierney J; Fisher D; Parmar MK; Arriagada R; Pignon JP; Le Pechoux C;
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD002142. PubMed ID: 27684386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database.
    Yang R; Gong J; Liao Z; Yu J; Zhang J; Xie C
    Transl Cancer Res; 2022 Jul; 11(7):2194-2204. PubMed ID: 35966291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer.
    Kim BH; Kim JS; Kim HJ
    Radiat Oncol J; 2023 Sep; 41(3):144-153. PubMed ID: 37793623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
    Wang W; Men Y; Wang J; Zhou Z; Chen D; Xiao Z; Feng Q; Lv J; Liang J; Bi N; Gao S; Wang L; Hui Z
    BMC Cancer; 2019 May; 19(1):478. PubMed ID: 31113432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
    Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
    J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative radiotherapy for lung cancer: Is it worth the controversy?
    Billiet C; Peeters S; Decaluwé H; Vansteenkiste J; Mebis J; Ruysscher D
    Cancer Treat Rev; 2016 Dec; 51():10-18. PubMed ID: 27788387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.